Cannabidiol is being touted as a magical elixir, a cure-all now available in bath bombs, dog treats and even pharmaceuticals. But maybe it’s just a fix for our anxious times.
One of the world’s most popular newspapers, the NYTimes, just published a wonderful article on CBD and a general introduction to the industry. It’s great to see such huge exposure for the hemp and cbd industry.
It’s hard to say the precise moment when CBD, the voguish cannabis derivative, went from being a fidget spinner alternative for stoners to a mainstream panacea.
Maybe it was in January, when Mandy Moore, hours before the Golden Globes, told Coveteur that she was experimenting with CBD oil to relieve the pain from wearing high heels. “It could be a really exciting evening,” she said. “I could be floating this year.”
Maybe it was in July, when Willie Nelson introduced a line of CBD-infused coffee beans called Willie’s Remedy. “It’s two of my favorites, together in the perfect combination,” he said in a statement.
Or maybe it was earlier this month, when Dr. Sanjay Gupta gave a qualified endorsement of CBD on “The Dr. Oz Show.” “I think there is a legitimate medicine here,” he said. “We’re talking about something that could really help people.”
So the question now becomes: Is this the dawning of a new miracle elixir, or does all the hype mean we have already reached Peak CBD?
Either way, it would be hard to script a more of-the-moment salve for a nation on edge. With its proponents claiming that CBD treats ailments as diverse as inflammation, pain, acne, anxiety, insomnia, depression, post-traumatic stress and even cancer, it’s easy to wonder if this all natural, non-psychotropic and widely available cousin of marijuana represents a cure for the 21st century itself.
The ice caps are melting, the Dow teeters, and a divided country seems headed for divorce court. Is it any wonder, then, that everyone seems to be reaching for the tincture?
“Right now, CBD is the chemical equivalent to Bitcoin in 2016,” said Jason DeLand, a New York advertising executive and a board member of Dosist, a cannabis company in Santa Monica, Calif., that makes disposable vape pens with CBD. “It’s hot, everywhere and yet almost nobody understands it.”
As an alternative health regimen, CBD holds particular appeal to women, said Gretchen Lidicker, the health editor of Mindbodygreen, a wellness website based in New York, and the author of “CBD Oil Everyday Secrets.” Noting the preponderance of female-run CBD businesses, Ms. Lidicker, 26, said that it is “no surprise that women are leading the CBD movement.”
“Women have long felt ignored and dehumanized by the medical and health care industries,” she said. “They experience longer wait times for treatment. Their pain and suffering are more likely to be dismissed as anxiety or hysteria. And the male body has typically been the model for medical research.”
Such concerns seem to have helped fuel the CBD movement. In an era marked by a loss of faith traditional institutions (governments, banks, hospitals), CBD has flourished, perhaps because it seems new, mysterious and untainted by the mainstream.
Aside from a federal crackdown, the only thing that may eventually kill CBD’s momentum is hype itself, said Mr. DeLand of Dosist.
The frothy claims about CBD “sets up some false expectations that the molecule will never be able to live up to,” Mr. DeLand said. Not only are questionable claims an invitation for government regulation, but they risk making even legitimate applications seem dubious, he said.
“In isolation, CBD obviously does have some benefits, but it’s certainly not a catchall for all the world’s health problems,” he said. “We are at the tip of the iceberg on what its therapeutic applications are, and how to make those applications repeatable.”
“The future of this industry,” Mr. DeLand added, “is going to be based on fact, not fiction.”
Read the full article here on NYTimes.com